| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-30626-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86064-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-36567SS | |||
| Azide and BSA Free | NBP2-80653 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47698-0.1mg | |||
| IHC-Prediluted | NBP2-48132 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-91996-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71602 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63062-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71065 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70715 | |||
![Western Blot: APOA1BP Antibody [NBP2-30626] - Analysis in MCF-7 cells transfected with control siRNA, target specific siRNA probe #1, using Anti-NAXE antibody. Remaining relative intensity is presented. Loading control: Anti-GAPDH.](http://images.novusbio.com/fullsize/APOA1BP-Antibody-Western-Blot-NBP2-30626-img0005.jpg "<b>Genetic Strategies Validation. </b>Western Blot: APOA1BP Antibody [NBP2-30626] - Analysis in MCF-7 cells transfected with control siRNA, target specific siRNA probe #1, using Anti-NAXE antibody. Remaining relative intensity is presented. Loading control: Anti-GAPDH.")
![<b>Independent Antibodies Validation and Genetic Strategies Validation.</b>Immunohistochemistry-Paraffin: APOA1BP Antibody [NBP2-30626] - Staining of human cerebral cortex, kidney, lymph node and testis using Anti-NAXE antibody NBP2-30626 (A) shows similar protein distribution across tissues to independent antibody NBP2-30943 (B).](http://images.novusbio.com/fullsize/APOA1BP-Antibody-Immunohistochemistry-Paraffin-NBP2-30626-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: APOA1BP Antibody [NBP2-30626] - Staining of human cell line A549 shows localization to nucleoplasm & cytosol. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/APOA1BP-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-30626-img0004.jpg)
![Immunohistochemistry-Paraffin: APOA1BP Antibody [NBP2-30626] - Staining of human cerebral cortex.](http://images.novusbio.com/fullsize/APOA1BP-Antibody-Immunohistochemistry-Paraffin-NBP2-30626-img0011.jpg)
![Immunohistochemistry-Paraffin: APOA1BP Antibody [NBP2-30626] - Staining of human kidney.](http://images.novusbio.com/fullsize/APOA1BP-Antibody-Immunohistochemistry-Paraffin-NBP2-30626-img0008.jpg)
![Immunohistochemistry-Paraffin: APOA1BP Antibody [NBP2-30626] - Staining of human testis.](http://images.novusbio.com/fullsize/APOA1BP-Antibody-Immunohistochemistry-Paraffin-NBP2-30626-img0009.jpg)
![Immunohistochemistry-Paraffin: APOA1BP Antibody [NBP2-30626] - Staining of human lymph node.](http://images.novusbio.com/fullsize/APOA1BP-Antibody-Immunohistochemistry-Paraffin-NBP2-30626-img0010.jpg)
![Immunohistochemistry-Paraffin: BPGM Antibody [NBP1-86064] - Analysis in human placenta and liver tissues using NBP1-86064 antibody. Corresponding BPGM RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/BPGM-Antibody-Immunohistochemistry-Paraffin-NBP1-86064-img0013.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: BPGM Antibody [NBP1-86064] - Analysis in human placenta and liver tissues using NBP1-86064 antibody. Corresponding BPGM RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: BPGM Antibody [NBP1-86064] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/BPGM-Antibody-Immunohistochemistry-Paraffin-NBP1-86064-img0017.jpg)
![Immunohistochemistry-Paraffin: BPGM Antibody [NBP1-86064] - Staining of human placenta shows strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/BPGM-Antibody-Immunohistochemistry-Paraffin-NBP1-86064-img0014.jpg)
![Immunohistochemistry-Paraffin: BPGM Antibody [NBP1-86064] - Staining of human urinary bladder shows weak to moderate cytoplasmic positivity in urothelial cells.](http://images.novusbio.com/fullsize/BPGM-Antibody-Immunohistochemistry-Paraffin-NBP1-86064-img0015.jpg)
![Immunohistochemistry-Paraffin: BPGM Antibody [NBP1-86064] - Staining of human kidney shows weak to moderate cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/BPGM-Antibody-Immunohistochemistry-Paraffin-NBP1-86064-img0016.jpg)
![Western Blot: CD63 Antibody (7G4.2E8) [NBP2-36567] - Western blot analysis of mouse CD63 on recombinant mouse CD63 and mouse kidney lysate.](http://images.novusbio.com/fullsize/CD63-Antibody-7G4-2E8-Western-Blot-NBP2-36567-img0002.jpg "Western Blot: CD63 Antibody (7G4.2E8) [NBP2-36567] - Western blot analysis of mouse CD63 on recombinant mouse CD63 and mouse kidney lysate.")
![Flow Cytometry: CD63 Antibody (7G4.2E8) [NBP2-36567] - Intracellular staining of mouse CD63 in Flow cytometry using 2.0 ug of antibody per 1 million cells. Isotype control was rat IgG2a lambda.](http://images.novusbio.com/fullsize/CD63-Antibody-7G4-2E8-Flow-Cytometry-NBP2-36567-img0003.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - A. 30 ug PC-12 whole cell lysate/extract 7.5% SDS-PAGE tPA antibody dilution: 1:1000 The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Western-Blot-NBP2-20648-img0019.jpg "Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - A. 30 ug PC-12 whole cell lysate/extract 7.5% SDS-PAGE tPA antibody dilution: 1:1000 The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Colon carcinoma. tPA antibody dilution: 1:250. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP2-20648-img0021.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Sample (30 ug of whole cell lysate) A: 293T 7. 5% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Western-Blot-NBP2-20648-img0017.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Human hepatoma. tPA antibody dilution: 1:500. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP2-20648-img0020.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with t-Plasminogen Activator/tPA antibody (NBP2-20648) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20648_rabbit-polyclonal-t-plasminogen-activator-tpa-antibody-91020242011476.jpg)
![Western Blot: CEBP Delta Antibody [NB110-85519] - Lane 1: Human C/EBPbeta. Lane 2: Mouse C/EBPdelta. Lane 3: untransfected. Lane 4: Human C/EBPdelta. 35 ug per lane. Primary: Anti-C/EBPd antibody at 1:15k overnight at 4C. Blocking: buffer TBST ECL was used for detection of overexpressed protein in human and mouse C/EBP delta. Predicted/Observed size: 28.8 kDa, 35 kDa.](http://images.novusbio.com/fullsize/CEBP-Delta-Antibody-Western-Blot-NB110-85519-img0006.jpg "Western Blot: CEBP Delta Antibody [NB110-85519] - Lane 1: Human C/EBPbeta. Lane 2: Mouse C/EBPdelta. Lane 3: untransfected. Lane 4: Human C/EBPdelta. 35 ug per lane. Primary: Anti-C/EBPd antibody at 1:15k overnight at 4C. Blocking: buffer TBST ECL was used for detection of overexpressed protein in human and mouse C/EBP delta. Predicted/Observed size: 28.8 kDa, 35 kDa.")
![<b>Genetic Strategies Validation. </b>Western Blot: CEBP Delta Antibody [NB110-85519] - Detection of endogenous protein in whole cell extracts from mouse macrophage cells. Untreated WT cells (Lane 1), WT cells treated 3 hrs with LPS (Lane 2) and knock-out cells treated 3 hrs with LPS (Lane 3). The band at ~35 kDa, indicated by the arrowhead, corresponds to the expected molecular weight of endogenous C/EBP delta. Primary antibody at 1:15,000. ECL was used for detection.](http://images.novusbio.com/fullsize/CEBP-Delta-Antibody-Western-Blot-NB110-85519-img0001.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: CEBP Delta Antibody [NB110-85519] - Lane 1: untreated wild-type (WT) cells. Lane 2: WT cells treated 3 hrs with LPS. Lane 3: C/EBPd-knock-out cells treated 3 hrs with LPS. 35 ug per lane. Primary: anti-C/EBPd antibody at 1:15k overnight at 4C. Blocking: buffer TBST ECL was used for detection of endogenous protein in whole cell extracts from mouse primary macrophage cells. Predicted/Observed size: 28.8 kDa, 35 kDa.](http://images.novusbio.com/fullsize/CEBP-Delta-Antibody-Western-Blot-NB110-85519-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - Immunofluorescence Analysis of HeLa cells labeled with alpha-Smooth Muscle Actin Antibody (ACTA/791) followed by Goat anti-Mouse IgG-CF488(Green). The nuclear counterstain is NucSpot (Red).](http://images.novusbio.com/fullsize/alpha-Smooth-Muscle-Actin-Antibody-ACTA2-791-Immunocytochemistry-Immunofluorescence-NBP2-44463-img0008.jpg "Immunocytochemistry/Immunofluorescence: alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - Immunofluorescence Analysis of HeLa cells labeled with alpha-Smooth Muscle Actin Antibody (ACTA/791) followed by Goat anti-Mouse IgG-CF488(Green). The nuclear counterstain is NucSpot (Red).")
![Immunohistochemistry-Paraffin: alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - Rat Lung stained with alpha-Smooth Muscle Actin Monoclonal Antibody (ACTA2/791).](http://images.novusbio.com/fullsize/alpha-Smooth-Muscle-Actin-Antibody-ACTA2-791-Immunohistochemistry-Paraffin-NBP2-44463-img0004.jpg)
![Flow (Intracellular): alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - An intracellular stain was performed on HeLa cells with alpha-Smooth Muscle Actin Antibody (ACTA2/791) NBP2-47698PCP (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to PerCP.](http://images.novusbio.com/fullsize/alpha-Smooth-Muscle-Actin-Antibody-ACTA2-791-Flow-Intracellular-NBP2-44463-img0007.jpg)
![Immunohistochemistry-Paraffin: alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - Human Angiosarcoma stained with alpha-Smooth Muscle Actin Monoclonal Antibody (ACTA2/791).](http://images.novusbio.com/fullsize/alpha-Smooth-Muscle-Actin-Antibody-ACTA2-791-Immunohistochemistry-Paraffin-NBP2-44463-img0001.jpg)
![Immunohistochemistry-Paraffin: alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - Human Colon Carcinoma stained with alpha-Smooth Muscle Actin Monoclonal Antibody (ACTA2/791).](http://images.novusbio.com/fullsize/alpha-Smooth-Muscle-Actin-Antibody-ACTA2-791-Immunohistochemistry-Paraffin-NBP2-44463-img0002.jpg)
![Immunohistochemistry-Paraffin: alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - Human Leiomyosarcoma stained with alpha-Smooth Muscle Actin Monoclonal Antibody (ACTA2/791).](http://images.novusbio.com/fullsize/alpha-Smooth-Muscle-Actin-Antibody-ACTA2-791-Immunohistochemistry-Paraffin-NBP2-44463-img0003.jpg)
![Flow Cytometry: alpha-Smooth Muscle Actin Antibody (ACTA2/791) [NBP2-44463] - An intracellular stain was performed on HepG2 cells with alpha-Smooth Muscle Actin Antibody (ACTA2/791) NBP2-47698PE (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to phycoerythrin.](http://images.novusbio.com/fullsize/alpha-Smooth-Muscle-Actin-Antibody-ACTA2-791-Flow-Cytometry-NBP2-44463-img0006.jpg)
![Immunohistochemistry-Paraffin: HMG-CoA Reductase/HMGCR Antibody [NBP1-91996] - Staining of human gastrointestinal shows moderate granular cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/HMG-CoA-Reductase-HMGCR-Antibody-Immunohistochemistry-Paraffin-NBP1-91996-img0008.jpg "Immunohistochemistry-Paraffin: HMG-CoA Reductase/HMGCR Antibody [NBP1-91996] - Staining of human gastrointestinal shows moderate granular cytoplasmic positivity in glandular cells.")
![Immunohistochemistry-Paraffin: HMG-CoA Reductase/HMGCR Antibody [NBP1-91996] - Staining of human cerebral cortex shows moderate granular cytoplasmic positivity in neurons.](http://images.novusbio.com/fullsize/HMG-CoA-Reductase-HMGCR-Antibody-Immunohistochemistry-Paraffin-NBP1-91996-img0005.jpg)
![Immunohistochemistry-Paraffin: HMG-CoA Reductase/HMGCR Antibody [NBP1-91996] - Staining of human kidney shows moderate granular cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/HMG-CoA-Reductase-HMGCR-Antibody-Immunohistochemistry-Paraffin-NBP1-91996-img0006.jpg)
![Immunohistochemistry-Paraffin: HMG-CoA Reductase/HMGCR Antibody [NBP1-91996] - Staining of human placenta shows moderate granular cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/HMG-CoA-Reductase-HMGCR-Antibody-Immunohistochemistry-Paraffin-NBP1-91996-img0007.jpg)
![Western Blot: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of extracts (35ug) from 9 different cell lines (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Western-Blot-NBP2-46477-img0009.jpg "Western Blot: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of extracts (35ug) from 9 different cell lines (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).")
![Immunohistochemistry: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Immunohistochemistry-NBP2-46477-img0007.jpg)
![Western Blot: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ACAA2.](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Western-Blot-NBP2-46477-img0008.jpg)
![Western Blot: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of extracts (10ug) from 7 Human tissues ( 1: Uterus; 2: Breast; 3: Brain; 4: Liver; 5: Ovary; 6: Thyroid gland; 7: colon)](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Western-Blot-NBP2-46477-img0010.jpg)
![Immunohistochemistry: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Immunohistochemistry-NBP2-46477-img0003.jpg)
![Immunohistochemistry: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Immunohistochemistry-NBP2-46477-img0004.jpg)
![Immunohistochemistry: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Immunohistochemistry-NBP2-46477-img0005.jpg)
![Immunohistochemistry: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Immunohistochemistry-NBP2-46477-img0006.jpg)
![Immunofluorescence: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY ACAA2.](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Immunofluorescence-NBP2-46477-img0001.jpg)
![Immunofluorescence: ACAA2 Antibody (OTI1C10) [NBP2-46477] - Analysis of HeLa cells.](http://images.novusbio.com/fullsize/ACAA2-Antibody-OTI1C10-Immunofluorescence-NBP2-46477-img0002.jpg)
![CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Lysozyme-Antibody-BGN-0696-5B1-CyTOF-ready-NB100-63062-img0001.jpg "CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.")
![Western Blot: Kir3.1 Antibody (1G3) [NBP2-01702] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Kir3.1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Kir3.1.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Western-Blot-NBP2-01702-img0003.jpg "Western Blot: Kir3.1 Antibody (1G3) [NBP2-01702] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Kir3.1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Kir3.1.")
![Immunocytochemistry/Immunofluorescence: Kir3.1 Antibody (1G3) [NBP2-01702] Staining of COS7 cells transiently transfected by pCMV6-ENTRY Kir3.1.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Immunocytochemistry-Immunofluorescence-NBP2-01702-img0009.jpg)
![Immunohistochemistry-Paraffin: Kir3.1 Antibody (1G3) [NBP2-01702] - Staining of paraffin-embedded Human prostate tissue using anti-Kir3.1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Immunohistochemistry-Paraffin-NBP2-01702-img0008.jpg)
![Flow Cytometry: Kir3.1 Antibody (1G3) [NBP2-01702] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-Kir3.1 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Flow-Cytometry-NBP2-01702-img0002.jpg)
![Immunohistochemistry-Paraffin: Kir3.1 Antibody (1G3) [NBP2-01702] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-Kir3.1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Immunohistochemistry-Paraffin-NBP2-01702-img0004.jpg)
![Immunohistochemistry-Paraffin: Kir3.1 Antibody (1G3) [NBP2-01702] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-Kir3.1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Immunohistochemistry-Paraffin-NBP2-01702-img0005.jpg)
![Immunohistochemistry-Paraffin: Kir3.1 Antibody (1G3) [NBP2-01702] - Staining of paraffin-embedded Human endometrium tissue using anti-Kir3.1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Immunohistochemistry-Paraffin-NBP2-01702-img0006.jpg)
![Immunohistochemistry-Paraffin: Kir3.1 Antibody (1G3) [NBP2-01702] - Staining of paraffin-embedded Human Kidney tissue using anti-Kir3.1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Immunohistochemistry-Paraffin-NBP2-01702-img0007.jpg)
![Flow Cytometry: Kir3.1 Antibody (1G3) [NBP2-01702] - Analysis of Jurkat cells, using anti-Kir3.1 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/Kir3-1-Antibody-1G3-Flow-Cytometry-NBP2-01702-img0001.jpg)
![Western Blot: FDFT1 Antibody (2F10) [NBP2-01170] Analysis of extracts (35ug) from 9 different cell lines by using anti-FDFT1 monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Western-Blot-NBP2-01170-img0011.jpg "Western Blot: FDFT1 Antibody (2F10) [NBP2-01170] Analysis of extracts (35ug) from 9 different cell lines by using anti-FDFT1 monoclonal antibody.")
![Immunocytochemistry/Immunofluorescence: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY FDFT1.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunocytochemistry-Immunofluorescence-NBP2-01170-img0010.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Human prostate tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0009.jpg)
![Western Blot: FDFT1 Antibody (2F10) [NBP2-01170] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FDFT1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FDFT1.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Western-Blot-NBP2-01170-img0001.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0002.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0003.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Human breast tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0004.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Human endometrium tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0005.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Human Kidney tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0006.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Human liver tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0007.jpg)
![Immunohistochemistry-Paraffin: FDFT1 Antibody (2F10) [NBP2-01170] - Staining of paraffin-embedded Human lymphoma tissue using anti-FDFT1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/FDFT1-Antibody-2F10-Immunohistochemistry-Paraffin-NBP2-01170-img0008.jpg)
![Western Blot: Apolipoprotein D Antibody [NBP2-42526] - Analysis of Human Liver lysate (35 ug protein in RIPA buffer). Antibody at 0.3 ug/mL. Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Apolipoprotein-D-Antibody-Western-Blot-NBP2-42526-img0002.jpg "Western Blot: Apolipoprotein D Antibody [NBP2-42526] - Analysis of Human Liver lysate (35 ug protein in RIPA buffer). Antibody at 0.3 ug/mL. Primary incubation was 1 hour. Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: Apolipoprotein D Antibody [NBP2-42526] - Figure 4. ApoA1, ApoD (Apolipoprotein D), and LCAT immunolabeling in cultured keratocytes, dermal fibroblasts, and HepG2 liver cells. Cells were immunolabeled with ApoD (d-f) antibodies (green). DAPI was used to visualize DNA (blue). Anti-ApoD immunolabeled keratocytes (d) and dermal fibroblasts (e), but not HepG2 cells (f). Image collected and cropped by CiteAb from the following publication (www.mdpi.com/2218-273X/9/12/785/htm) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Apolipoprotein-D-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-42526-img0005.jpg)
![Immunohistochemistry-Paraffin: Apolipoprotein D Antibody [NBP2-42526] - Staining of paraffin embedded Human Adrenal Gland. Antibody at 5 ug/mL. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/Apolipoprotein-D-Antibody-Immunohistochemistry-Paraffin-NBP2-42526-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: Apolipoprotein D Antibody [NBP2-42526] - Immunostaining of apolipoprotein (Apo)A1, ApoD (Apolipoprotein D), and lecithin:cholesterol acyltransferase (LCAT) in the human central cornea. Frozen sections from an individual cornea were incubated at 4 C with either anti-ApoA1 (a) or LCAT (o) antibodies (green). Nuclei were stained blue with DAPI. Antibodies were detected as described in the Materials and Methods. The epithelium, stromal keratocytes, and endothelium showed staining of LCAT (o). Image collected and cropped by CiteAb from the following publication (www.mdpi.com/2218-273X/9/12/785) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Apolipoprotein-D-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-42526-img0004.jpg)
![Immunohistochemistry-Paraffin: Apolipoprotein D Antibody [NBP2-42526] - Staining of paraffin embedded Human Kidney. Antibody at 5 ug/mL. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/Apolipoprotein-D-Antibody-Immunohistochemistry-Paraffin-NBP2-42526-img0001.jpg)
